Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YDR369C | XRS2 | SGDID:S000002777 | TP53BP1 |
TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) |
Homo sapiens | Follicular Adenoma,Microcephaly Chorioretinopathy Recessive Form,Dyskeratosis Congenita,Cerebellar Disease,Autosomal Recessive Chorioretinopathy-Microcephaly Syndrome,Primary Hyperoxaluria,Breast Cancer,Severe Combined Immunodeficiency With Sensitivity To Ionizing Radiation,Microcephaly,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Hutchinson-Gilford Progeria Syndrome,Myeloproliferative Disorder, Chronic, With Eosinophilia,Seckel Syndrome,Riddle Syndrome,Microcephaly And Chorioretinopathy, Autosomal Recessive, 3,Lig4 Syndrome,Pigmentary Disorder, Reticulate, With Systemic Manifestations, X-Linked,Autosomal Recessive Cerebellar Ataxia,Ataxia-Telangiectasia,Primary Autosomal Recessive Microcephaly |
1gzh_b | Q12888 | ENSG00000067369 | TP53BP1 | 98.60 | 9.20E-12 | 1.00E-15 | 120.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YDR369C | XRS2 | SGDID:S000002777 | RAD53 MEC2 SAD1 SPK1 YPL153C P2588 |
Serine/threonine-protein kinase RAD53 (EC 2.7.12.1) (CHEK2 homolog) (Serine-protein kinase 1) |
2.7.12.1 | Saccharomyces cerevisiae | 1dmz_a | P22216 | 97.00 | 8.90E-07 | 8.10E-11 | 83.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR369C | XRS2 | SGDID:S000002777 | ECT2 |
Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) |
Homo sapiens | Breast Cancer,Gastric Cancer,Lung Squamous Cell Carcinoma,Lung Cancer |
4n40_a | Q9H8V3 | ENSG00000114346 | ECT2 | 98.40 | 5.60E-11 | 6.30E-15 | 116.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YDR369C | XRS2 | SGDID:S000002777 | DNL4 LIG4 YOR005C UND407 UNE452 |
DNA ligase 4 (EC 6.5.1.1) (DNA ligase II) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4) |
6.5.1.1 | Saccharomyces cerevisiae | 1z56_c | Q08387 | 97.80 | 7.90E-09 | 9.00E-13 | 99.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR369C | XRS2 | SGDID:S000002777 | TOPBP1 KIAA0259 |
DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1) |
Homo sapiens | Fanconi Anemia, Complementation Group J,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Seckel Syndrome,Ataxia-Telangiectasia |
2xnk_a | Q92547 | ENSG00000163781 | TOPBP1 | 98.50 | 1.40E-11 | 1.50E-15 | 123.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YDR369C | XRS2 | SGDID:S000002777 | RTT107 ESC4 YHR154W |
Regulator of Ty1 transposition protein 107 (Establishes silent chromatin protein 4) |
Saccharomyces cerevisiae | 3t7j_a | P38850 | 98.60 | 8.30E-12 | 8.70E-16 | 123.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR369C | XRS2 | SGDID:S000002777 | PAXIP1 PAXIP1L PTIP CAGF28 |
PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) |
Homo sapiens | Breast Cancer,Prostate Calculus,Kabuki Syndrome 1 |
3sqd_a | Q6ZW49 | ENSG00000157212 | PAXIP1 | 99.00 | 7.30E-14 | 8.30E-18 | 132.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YDR369C | XRS2 | SGDID:S000002777 | rad4 cut5 SPAC23C4.18c |
S-M checkpoint control protein rad4 (P74) (Protein cut5) |
Schizosaccharomyces pombe | 4bmd_a | P32372 | 98.10 | 6.10E-10 | 7.20E-14 | 101.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR369C | XRS2 | SGDID:S000002777 | MDC1 KIAA0170 NFBD1 |
Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1) |
Homo sapiens | Cerebellar Disease,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Seckel Syndrome,Riddle Syndrome,Lig4 Syndrome,Renal Cell Carcinoma, Nonpapillary,Nijmegen Breakage Syndrome,Ataxia-Telangiectasia,Primary Autosomal Recessive Microcephaly |
3k05_a | Q14676 | ENSG00000137337 | MDC1 | 99.00 | 7.30E-14 | 8.60E-18 | 128.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YDR369C | XRS2 | SGDID:S000002777 | TOPBP1 |
TOPBP1 |
Gallus gallus | 6hm5_a | A0A1D5P3M9 | 98.60 | 7.30E-12 | 7.90E-16 | 125.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR369C | XRS2 | SGDID:S000002777 | brc1 SPBC582.05c |
BRCT-containing protein 1 |
Schizosaccharomyces pombe | 3l40_a | Q10337 | 98.80 | 5.40E-13 | 6.40E-17 | 124.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR369C | XRS2 | SGDID:S000002777 | BARD1 |
BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1) |
2.3.2.27 | Homo sapiens | Cowden Syndrome,Plasma Cell Neoplasm,Fallopian Tube Carcinoma,Neuroblastoma,Inherited Cancer-Predisposing Syndrome,Sporadic Breast Cancer,Ovarian Cancer,Breast Cancer,Hereditary Breast Ovarian Cancer Syndrome,Fanconi Anemia, Complementation Group A,Lynch Syndrome,Gastric Cancer, Hereditary Diffuse,Tumor Predisposition Syndrome,Cutaneous Telangiectasia And Cancer Syndrome, Familial,Li-Fraumeni Syndrome,Myeloma, Multiple |
2nte_a | Q99728 | ENSG00000138376 | BARD1 | 98.40 | 5.20E-11 | 6.20E-15 | 109.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR369C | XRS2 | SGDID:S000002777 | crb2 rhp9 SPBC342.05 |
DNA repair protein crb2 (Checkpoint mediator protein crb2) (Cut5-repeat binding protein 2) (RAD9 protein homolog) |
Schizosaccharomyces pombe | 2vxb_a | P87074 | 98.40 | 3.80E-11 | 4.20E-15 | 115.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR369C | XRS2 | SGDID:S000002777 | MCPH1 |
Microcephalin |
Homo sapiens | Physical Disorder,Microcephaly 17, Primary, Autosomal Recessive,Microcephaly 9, Primary, Autosomal Recessive,Microcephaly 7, Primary, Autosomal Recessive,Microcephaly 6, Primary, Autosomal Recessive,Microcephaly 5, Primary, Autosomal Recessive,Congenital Nervous System Abnormality,Microcephaly 18, Primary, Autosomal Dominant,Microcephaly,Microcephaly 11, Primary, Autosomal Recessive,Disease Of Mental Health,Seckel Syndrome 4,Microcephaly 2, Primary, Autosomal Recessive, With Or Without Cortical Malformations,Microcephaly 4, Primary, Autosomal Recessive,Seckel Syndrome 5,Microcephaly 3, Primary, Autosomal Recessive,Periventricular Nodular Heterotopia,Microcephaly 13, Primary, Autosomal Recessive,Microcephaly 12, Primary, Autosomal Recessive,Seckel Syndrome,Seckel Syndrome 2,Miller-Dieker Lissencephaly Syndrome,Microcephaly 8, Primary, Autosomal Recessive,Microcephaly 1, Primary, Autosomal Recessive,Autosomal Recessive Non-Syndromic Intellectual Disability,Ataxia-Telangiectasia,Autism,Microcephalic Osteodysplastic Primordial Dwarfism, Type Ii,Primary Autosomal Recessive Microcephaly,Primary Microcephaly,Band Heterotopia,Isolated Growth Hormone Deficiency, Type Ia |
3t1n_a | Q8NEM0 | ENSG00000147316 | MCPH1 | 98.70 | 1.40E-12 | 1.70E-16 | 119.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YDR369C | XRS2 | SGDID:S000002777 | BRCA1 RNF53 |
Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) |
2.3.2.27 | Homo sapiens | Cancerophobia,Skin Melanoma,Ovarian Carcinosarcoma,Uterine Carcinosarcoma,Endometrial Cancer,Peritoneum Cancer,Endosalpingiosis,Ganglioneuroblastoma,Breast-Ovarian Cancer, Familial 2,Retinitis Pigmentosa,Adenoid Cystic Carcinoma,Cowden Syndrome,Cowden Syndrome 1,Primary Peritoneal Carcinoma,Cervical Adenoma Malignum,Fallopian Tube Disease,Fallopian Tube Carcinoma,Bilateral Breast Cancer,Synchronous Bilateral Breast Carcinoma,B-Lymphoblastic Leukemia/Lymphoma,Uterine Corpus Cancer,B-Lymphoblastic Leukemia/Lymphoma With Hyperdiploidy,Dysgerminoma,Alzheimer Disease,Familiar Ovarian Carcinoma,Basaloid Lung Carcinoma,Malignant Ovarian Surface Epithelial-Stromal Neoplasm,Ovary Epithelial Cancer,Hereditary Site-Specific Ovarian Cancer Syndrome,Familial Ovarian Cancer,Amelogenesis Imperfecta,Ovarian Serous Cystadenofibroma,Female Reproductive System Disease,Neuroblastoma,Inherited Cancer-Predisposing Syndrome,Leukemia, Acute Myeloid,Sporadic Breast Cancer,Cystinuria,Thoracic Cancer,Canavan Disease,Papillary Serous Adenocarcinoma,Cystadenoma,Intracystic Papillary Adenoma,Mulchandani-Bhoj-Conlin Syndrome,Dysplastic Nevus Syndrome,Bladder Cancer,Fallopian Tube Clear Cell Adenocarcinoma,Cerebellar Disease,Endocrine System Disease,Deafness, Autosomal Dominant 13,Fanconi Anemia, Complementation Group J,Ovarian Serous Adenofibroma,Cockayne Syndrome,Tetraploidy,Aplastic Anemia,Ovarian Cancer,Adenocarcinoma,In Situ Carcinoma,Female Reproductive Endometrioid Cancer,Breast Ductal Carcinoma,Lobular Neoplasia,Breast Carcinoma In Situ,Breast Cancer,Hereditary Breast Ovarian Cancer Syndrome,Colorectal Cancer,Hypertrophy Of Breast,Endometrial Serous Adenocarcinoma,Cystadenocarcinoma,Papillary Adenocarcinoma,Serous Cystadenocarcinoma,Premature Menopause,Microcephaly,Rhabdomyosarcoma,Werner Syndrome,Ovarian Cystadenoma,Ovarian Disease,Deficiency Anemia,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Palmoplantar Keratoderma, Punctate Type Ii,Skin Carcinoma,Gastric Cancer,Fanconi Anemia, Complementation Group S,Breast Disease,Prostate Cancer,Disease Of Mental Health,Ovarian Cystadenocarcinoma,Contractures, Pterygia, And Spondylocarpotarsal Fusion Syndrome 1a,Congenital Myasthenic Syndrome,Mutagen Sensitivity,Breast Fibroadenoma,Fallopian Tube Adenocarcinoma,Ovary Adenocarcinoma,Breast-Ovarian Cancer, Familial 1,Ruvalcaba Syndrome,Lynch Syndrome,Lung Squamous Cell Carcinoma,Ovary Transitional Cell Carcinoma,Neural Tube Defects,Fanconi Anemia, Complementation Group D1,Cockayne Syndrome B,Seckel Syndrome,Tooth Agenesis,Body Mass Index Quantitative Trait Locus 20,Riddle Syndrome,Female Breast Cancer,Gastric Cancer, Hereditary Diffuse,Pancreatic Cancer 4,Tumor Predisposition Syndrome,Autosomal Genetic Disease,Ewing Sarcoma,Pigmentary Disorder, Reticulate, With Systemic Manifestations, X-Linked,Nephrolithiasis/Osteoporosis, Hypophosphatemic, 2,Salivary Gland Carcinoma,Cutaneous Telangiectasia And Cancer Syndrome, Familial,Ovarian Serous Carcinoma,Autosomal Recessive Cerebellar Ataxia,Nosophobia,Pre-Malignant Neoplasm,Ductal Carcinoma In Situ,Estrogen-Receptor Positive Breast Cancer,Estrogen-Receptor Negative Breast Cancer,Breast Benign Neoplasm,Thoracic Benign Neoplasm,Ovarian Benign Neoplasm,Nijmegen Breakage Syndrome,Li-Fraumeni Syndrome,Ovarian Cancer 1,Punctate Palmoplantar Keratoderma,Myasthenic Syndrome, Congenital, 6, Presynaptic,Ataxia-Telangiectasia,Medulloblastoma,Melanoma, Cutaneous Malignant 1,Melanoma, Uveal,Bloom Syndrome,Primary Autosomal Recessive Microcephaly,Lung Cancer,Pancreatic Cancer |
4igk_a | P38398 | ENSG00000012048 | BRCA1 | 98.70 | 3.30E-12 | 4.00E-16 | 117.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR369C | XRS2 | SGDID:S000002777 | Tb927.7.2480 |
Tb927.7.2480 |
Trypanosoma brucei | 2n84_a | Q57XM6 | 97.10 | 4.60E-07 | 4.90E-11 | 84.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR369C | XRS2 | SGDID:S000002777 | nbs1 SPBC6B1.09c |
DNA repair and telomere maintenance protein nbs1 |
Schizosaccharomyces pombe | 3huf_b | O43070 | 100.00 | 4.20E-39 | 4.60E-43 | 329.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |